PDCD1 and neoplasm: Although not designed to specifically effect macrophage function, studies in mouse models of cancer have shown that anti-PD-1/PD-L1 blockage in vivo increases macrophage phagocytosis with subsequent reduction in tumor growth and prolonged survival [63].